Guangzhou Respiratory Drug Engineering Technology

Guangzhou Respiratory Drug Engineering Technology is a specialized biotechnology company focused on the research, development, and commercialization of innovative treatments for respiratory diseases. Closely affiliated with the Guangzhou Institute of Respiratory Health and the State Key Laboratory of Respiratory Disease, the company leverages deep clinical expertise to address unmet needs in pulmonary medicine. Its portfolio includes novel antivirals for influenza and COVID-19, as well as advanced inhaled therapies for chronic conditions like asthma and COPD. The company plays a pivotal role in the regional biotech ecosystem in Guangdong, bridging the gap between academic respiratory research and industrial drug production.